Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05379972
Title Phase II Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Olaparib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST